To clarify your point re: Gen 2 and particularly Gen 3.
The new combination single pill alone cured around 70% of these patients.
However, with the addition of Ribavirin the response rate was 100%.
G3 and relapsers, together with certain subtypes, will go twelve weeks instead of eight AND use Ribavirin. IMO the other combos are not in the race until they can supply a once per day six/eight week course.
Gen 1 is far and away the most common variant in the west.
- Forums
- ASX - By Stock
- Hep C - adherence issues
To clarify your point re: Gen 2 and particularly Gen 3. The new...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online